APA

Muroski M. E., Roycik M. D., Newcomer R. G., Van den Steen P. E., Opdenakker G., Monroe H. R., Sahab Z. J. & Sang Q. (20080410). Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. : Current pharmaceutical biotechnology.

Chicago

Muroski M E, Roycik M D, Newcomer R G, Van den Steen P E, Opdenakker G, Monroe H R, Sahab Z J and Sang Q-X. 20080410. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. : Current pharmaceutical biotechnology.

Harvard

Muroski M. E., Roycik M. D., Newcomer R. G., Van den Steen P. E., Opdenakker G., Monroe H. R., Sahab Z. J. and Sang Q. (20080410). Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. : Current pharmaceutical biotechnology.

MLA

Muroski M E, Roycik M D, Newcomer R G, Van den Steen P E, Opdenakker G, Monroe H R, Sahab Z J and Sang Q-X. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. : Current pharmaceutical biotechnology. 20080410.